Related references
Note: Only part of the references are listed.Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
Nina N. Hosmane et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents
Janka Petravic et al.
JOURNAL OF VIROLOGY (2017)
The potential role for romidepsin as a component in early HIV-1 curative efforts
Jesper Damsgaard Gunst et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
Alexandra J. Murray et al.
JOURNAL OF IMMUNOLOGY (2016)
Residual Viremia in Treated HIV+ Individuals
Jessica M. Conway et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Insufficient Evidence for Rare Activation of Latent HIV in the Absence of Reservoir-Reducing Interventions
Alison L. Hill et al.
PLOS PATHOGENS (2016)
Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days
Mykola Pinkevych et al.
PLOS PATHOGENS (2016)
Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers
Benjamin B. Policicchio et al.
PLOS PATHOGENS (2016)
Animal Models for HIV Cure Research
Benjamin B. Policicchio et al.
FRONTIERS IN IMMUNOLOGY (2016)
Analysis of Practical Identifiability of a Viral Infection Model
Van Kinh Nguyen et al.
PLOS ONE (2016)
Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies
Shenshen Wang et al.
CELL (2015)
Long-Term Control of Simian Immunodeficiency Virus (SIV) in Cynomolgus Macaques Not Associated with Efficient SIV-Specific CD8+ T-Cell Responses
Timothee Bruel et al.
JOURNAL OF VIROLOGY (2015)
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Kai Deng et al.
NATURE (2015)
Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising
Shishi Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Post-treatment control of HIV infection
Jessica M. Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
Stefany Moreno-Gamez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Simple Mathematical Models Do Not Accurately Predict Early SIV Dynamics
Cecilia Noecker et al.
VIRUSES-BASEL (2015)
Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells
Ruian Ke et al.
PLOS PATHOGENS (2015)
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission
Mykola Pinkevych et al.
PLOS PATHOGENS (2015)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Sogaard et al.
PLOS PATHOGENS (2015)
T Memory Stem Cells and HIV: a Long-Term Relationship
Ann Chahroudi et al.
CURRENT HIV/AIDS REPORTS (2015)
Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines
Tomas Hanke
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Switching Strategies to Mitigate HIV Mutation
Esteban Abelardo Hernandez-Vargas et al.
IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY (2014)
Towards a cure for HIV-are we making progress?
Sharon R. Lewin et al.
LANCET (2014)
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
James B. Whitney et al.
NATURE (2014)
HIV-1 persistence in CD4+ T cells with stem cell like properties
Maria J. Buzon et al.
NATURE MEDICINE (2014)
Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy
Anthony R. Cillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Alison L. Hill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
HIV cure research: Advances and prospects
Caroline P. Passaes et al.
VIROLOGY (2014)
Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells
S. Jaafoura et al.
NATURE COMMUNICATIONS (2014)
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H. Elliott et al.
PLOS PATHOGENS (2014)
Computational Study to Determine When to Initiate and Alternate Therapy in HIV Infection
Matthias Haering et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Mathematical Modeling of HIV Dynamics After Antiretroviral Therapy Initiation: A Review
Pablo S. Rivadeneira et al.
BIORESEARCH OPEN ACCESS (2014)
Optimal therapy scheduling for a simplified HIV infection model
Esteban A. Hernandez-Vargas et al.
AUTOMATICA (2013)
Targeting HIV latency: pharmacologic strategies toward eradication
Sifei Xing et al.
DRUG DISCOVERY TODAY (2013)
Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design
Andrew L. Ferguson et al.
IMMUNITY (2013)
Modeling the three stages in HIV infection
Esteban A. Hernandez-Vargas et al.
JOURNAL OF THEORETICAL BIOLOGY (2013)
Contribution of Follicular Dendritic Cells to Persistent HIV Viremia
Jingshan Zhang et al.
JOURNAL OF VIROLOGY (2013)
Past, present and future: 30 years of HIV research
Francoise Barre-Sinoussi et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Short-Course Antiretroviral Therapy in Primary HIV Infection
Sarah Fidler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cell-associated HIV RNA: a dynamic biomarker of viral persistence
Alexander O. Pasternak et al.
RETROVIROLOGY (2013)
HIV-1 transcription and latency: an update
Carine Van Lint et al.
RETROVIROLOGY (2013)
Comparison of HDAC inhibitors in clinical development Effect on HIV production in latently infected cells and T-cell activation
Thomas Aagaard Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Cell-mediated immunity in elite controllers naturally controlling HIV viral load
Luca Genovese et al.
FRONTIERS IN IMMUNOLOGY (2013)
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Evelyn Eisele et al.
IMMUNITY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
Daniel I. S. Rosenbloom et al.
NATURE MEDICINE (2012)
Eliminating the HIV Reservoir
Alain Lafeuillade
CURRENT HIV/AIDS REPORTS (2012)
Towards an HIV cure: a global scientific strategy
Steven G. Deeks
NATURE REVIEWS IMMUNOLOGY (2012)
Nonlinear observer output-feedback MPC treatment scheduling for HIV
Ryan Zurakowski
BIOMEDICAL ENGINEERING ONLINE (2011)
Discrete-time control for switched positive systems with application to mitigating viral escape
Esteban Hernandez-Vargas et al.
INTERNATIONAL JOURNAL OF ROBUST AND NONLINEAR CONTROL (2011)
A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
Jessica M. Conway et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Enhancement of the immune system in HIV dynamics by output feedback
H. Chang et al.
AUTOMATICA (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips
Libin Rong et al.
MATHEMATICAL BIOSCIENCES (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection
Ian B. Hogue et al.
JOURNAL OF GENERAL VIROLOGY (2008)
A stochastic model for internal HIV dynamics
Nirav Dalal et al.
JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS (2008)
Dynamics of Immune Escape during HIV/SIV Infection
Christian L. Althaus et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Towards a long-term model construction for the dynamic simulation of hiv infection
M. Hadjiandreou et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2007)
Understanding the slow depletion of memory CD4+ T cells in HIV infection
Andrew Yates et al.
PLOS MEDICINE (2007)
Modelling of HIV infection: Vaccine readiness, drug effectiveness and therapeutical failures
Xiaohua Xia
JOURNAL OF PROCESS CONTROL (2007)
Persistence of replication-competent HIV in the central nervous system despite long-term effective highly active antiretroviral therapy
O Lambotte et al.
AIDS (2005)
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-Cell decay in vivo
M Markowitz et al.
JOURNAL OF VIROLOGY (2003)
Optimal control of an HIV immunology model
HR Joshi
OPTIMAL CONTROL APPLICATIONS & METHODS (2002)
Modelling viral and immune system dynamics
AS Perelson
NATURE REVIEWS IMMUNOLOGY (2002)
Management of antiretroviral therapy for HIV infection: Analyzing when to change therapy
RM D'Amato et al.
MANAGEMENT SCIENCE (2000)
Share Paper
